Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Leading Experimental Medicine and MRC Professor, Katja Simon, heads a team of scientists in developing a new method of boosting the ageing immune system using the naturally occurring chemical compound spermidine. Spermidine has potential to make vaccines more effective in the elderly, which in future could help protect this vulnerable population from seasonal flu and other infections.

Similar stories

A global collaboration to develop next-generation COVID-19 and flu vaccines

Today Oxford University has launched a new global collaboration backed by £8 million funding from UK Research and Innovation (UKRI). The project will be spearheaded by Professor Teresa Lambe, Professor of Vaccinology and Immunology and Calleva Head of Vaccine Immunology in the Department of Paediatrics and Professor Paul Klenerman, Sidney Truelove Professor of Gastroenterology and Director of the Translational Gastroenterology Unit at NDM, both of whom are Principal Investigators at NDM’s Pandemic Sciences Institute.